Sanofi: Sanofi/Regeneron's Dupixent granted FDA approval for chronic spontaneous urticaria
More than 300,000 people in the US are living with uncontrolled cases of the inflammatory skin disease
Read full article »
Sanofi is a France-based healthcare firm that develops and markets pharmaceutical drugs and OTC medicines for the treatment of a range of diseases such as diabetes and cancer.
Read more